Postoperative recovery of trigger finger release comparing two surgical techniques: ultrasound-guided and open release
| ISRCTN | ISRCTN47509548 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN47509548 |
| Sponsor | AZ Maria Middelares |
| Funder | Investigator initiated and funded |
- Submission date
- 07/02/2026
- Registration date
- 25/02/2026
- Last edited
- 23/02/2026
- Recruitment status
- No longer recruiting
- Overall study status
- Ongoing
- Condition category
- Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Plain English summary of protocol not provided at time of registration
Contact information
Dr Michiel Cromheecke
Public, Scientific, Principal investigator
Public, Scientific, Principal investigator
Buitenring-Sint-Denijs 30
Gent
9000
Belgium
| Phone | +32498855836 |
|---|---|
| michiel.cromheecke@mijnziekenhuis.be |
Study information
| Primary study design | Observational |
|---|---|
| Observational study design | Cohort study |
| Scientific title | Clinical outcomes after trigger finger release: a prospective comparison of ultrasound-guided and open techniques |
| Study acronym | RECOVER-TF |
| Study objectives | |
| Ethics approval(s) |
Approved 14/07/2025, Ethics Committee AZ Maria Middelares - AZ Sint-Vincentius Deinze (Buitenring-Sint-Denijs 30, Gent, 9000, Belgium; +3292461910; ethisch.comite@mijnziekenhuis.be), ref: MMS.2025.027 |
| Health condition(s) or problem(s) studied | Trigger finger |
| Methodology | This study is designed as a prospective, observational cohort study including all patients undergoing surgical treatment for trigger finger at a single referral hand surgery centre (Maria Middelares Hospital, Ghent, Belgium) beginning in May 2025. A minimum of 100 patients (50 per treatment arm) will be enrolled and managed using one of two established surgical techniques for trigger finger release: open release or ultrasound-guided release. Allocation to surgery Treatment allocation followed a pragmatic, patient-preference design. Patients selected their treating surgeon, and since each participating surgeon exclusively performed one standardized technique, this results in an expertise-based allocation model. Although non-randomized, this design reflects real-world clinical practice and minimizes the "learning curve" bias often seen in randomized trials. To minimize intra-group variability, all participating surgeons are fellowship-trained hand surgeons with high annual volumes in their respective techniques. Accordingly, two cohorts were defined: • Group A: Open trigger finger release performed by surgeon P.C. • Group B: Ultrasound-guided release performed by M.C., J.G. and P.B.D.K. This pragmatic allocation method ensures that each technique is performed by a highly skilled surgeon while minimizing variability within treatment groups. In addition, surgeon-related variation will be addressed analytically as described in the statistical analysis section below. Preoperative and postoperative assessments were standardized, and all patients received the same postoperative rehabilitation protocol and analgesics. Patients will be followed prospectively using standardized questionnaires and clinical examinations at the following postoperative time points: 1, 2, 3 and 4 weeks, 3 months, and 6 months. Clinical follow-up will be performed preoperatively, at 4 weeks, and at 3 months. Outcomes will be measured by QuickDASH, Patient and Observer Scar Assessment Scale (POSAS) and Visual Analog Scale (VAS) as well as standard clinical tests such as grip strength. Statistical analysis will be performed on anonymized data using IBM® SPSS® Statistics. A two-sided p-value < 0.05 will be considered statistically significant except where multiplicity adjustments are needed. Descriptive and comparative analyses will be performed. All primary analyses will follow an intention-to-treat (ITT) principle, with patients analysed in the group corresponding to the surgical technique performed. A per-protocol analysis will be performed as sensitivity analysis. Baseline characteristics will be summarized using descriptive statistics. Between-group comparisons (open versus ultrasound-guided trigger finger release) will be performed using independent-samples t-tests or Mann–Whitney U tests for continuous variables, and chi-square or Fisher’s exact tests for categorical variables, as appropriate. Analysis of covariance (ANCOVA) will be used to compare between-group outcomes while adjusting for baseline values of the outcome measure, in order to account for potential baseline imbalance and to increase statistical power in this non-randomized study design. Power calculation and sample size rationale for the primary outcome (QuickDASH change at 4 weeks) was performed. We plan a pragmatic, prospective, 2-arm study with equal allocation to open and ultrasound-guided trigger finger release. Assuming a literature-derived minimal clinically important difference (MCID) of 14 points and a standard deviation of 20 points, a two-sample t-test with a two-sided α = 0.05 requires 32 patients per group to achieve 80% power. To account for an anticipated 10% loss to follow-up and to increase the robustness and reliability of the findings, we plan to include 50 patients per group. Since ANCOVA typically increases power the above power calculation should be sufficient. To address potential confounding due to non-randomized treatment assignment multivariate regression models will adjust for baseline characteristics such as age, sex, symptom duration, hand dominance, diabetes, severity scores, occupation (manual vs administrative). Propensity score matching or weighting may be performed as sensitivity analysis if group imbalance occurs. Results will include estimates, 95% CIs and exact p-values. We will follow STROBE guidelines for observational cohort reporting and provide a flowchart of included/excluded patients. |
| Intervention type | Procedure/Surgery |
| Primary outcome measure(s) |
|
| Key secondary outcome measure(s) |
|
| Completion date | 04/07/2027 |
Eligibility
| Participant type(s) | |
|---|---|
| Age group | Mixed |
| Lower age limit | 18 Years |
| Upper age limit | 99 Years |
| Sex | All |
| Target sample size at registration | 100 |
| Key inclusion criteria | 1. Age between 18 and 99 years 2. All consecutive patients receiving surgical treatment for solitary trigger finger release 3. Undergoing surgery at VZW AZ Maria Middelares hospital |
| Key exclusion criteria | 1. Concomitant surgical procedures in the same hand 2. Symptomatic osteoarthritis of the hand or wrist 3. Symptomatic confounding pathology of elbow or shoulder 4. Pregnancy 5. Dupuytren's disease with symptomatic MCP or PIP contracture 6. Bilateral trigger finger surgery within a 3-month interval 7. Active chemotherapy or malignancy 8. Inability to complete the follow-up questionnaires (language barrier, cognitive impairment, etc.) 9. Revision surgery |
| Date of first enrolment | 15/07/2025 |
| Date of final enrolment | 01/06/2026 |
Locations
Countries of recruitment
- Belgium
Study participating centre
VZW AZ Maria Middelares hospital
Buitenring-Sint-Denijs 30
Gent
9000
Belgium
Gent
9000
Belgium
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Protocol file | 09/02/2026 | No | No |
Additional files
- 49000_Protocol_18012026.pdf
- Protocol file
Editorial Notes
09/02/2026: Study’s existence confirmed by the Ethical Committee AZ Maria Middelares - AZ Sint Vincentius Deinze, Belgium.